Promis Neurosciences Inc (PMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 993 | 2,497 | 12,598 | 16,868 | 1,223 |
| Marketable Securities | 32 | 32 | 32 | 32 | 32 |
| TOTAL | $1,410 | $3,548 | $13,619 | $17,858 | $1,479 |
| Non-Current Assets | |||||
| Intangibles | 0 | 0 | 0 | 18 | 19 |
| TOTAL | $N/A | $N/A | $N/A | $18 | $19 |
| Total Assets | $1,410 | $3,548 | $13,619 | $17,876 | $1,498 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,015 | 1,404 | 7,843 | 8,415 | 7,963 |
| Accrued Expenses | 1,157 | 1,242 | 1,507 | 1,437 | 776 |
| TOTAL | $3,172 | $2,646 | $9,350 | $9,851 | $8,739 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 515 | 825 | 516 | 1,270 | 1,287 |
| TOTAL | $515 | $825 | $516 | $1,270 | $1,287 |
| Total Liabilities | $3,687 | $3,471 | $9,866 | $11,121 | $10,026 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,195 | 758 | 758 | 755 | 343 |
| Retained earnings | -99,725 | -97,101 | -93,466 | -89,886 | -87,525 |
| Other shareholders' equity | -371 | -371 | -371 | -371 | -371 |
| TOTAL | $-2,277 | $77 | $3,753 | $6,755 | $-8,528 |
| Total Liabilities And Equity | $1,410 | $3,548 | $13,619 | $17,876 | $1,498 |